By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen Biosystems said after the close of the market on Thursday that it has closed on its $7.2 million registered direct offering.

Net proceeds from the offering totaled about $6.7 million. The amount raised includes $1 million from Chairman and CEO Alnoor Shivji and about $500,000 in aggregate from four other board members.

Proceeds will be used for general working capital purposes and continued commercialization of its SmartChip Real-Time PCR System.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.